Checking monogenic diabetes wrongly labeled as type 1
Part of Brain & nervous system, Ear, nose & throat, Eyes & vision, Genetic & congenital, Hormones & metabolism, Immune system & allergy, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial looks at people who were diagnosed with diabetes before age 25 as either type 1 or “not sure which type.” It may help confirm whether the cause is genetic (monogenic) rather than type 1, which can change treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with diabetes before age 25.
- Your diabetes type was labeled as type 1 or still unclear.
- You have not already had diabetes autoantibody testing, or it was negative.
- If you previously had autoantibody testing and it was positive, you usually cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for people with a type of diabetes that runs in families, often diagnosed at a young age. It uses genetic testing to find the exact cause and then tailor treatment to each person.
This registry is for people who may have a genetic form of diabetes (monogenic diabetes) diagnosed at a young age. It collects information to better understand and diagnose these rare diabetes types.
This study is trying to identify maturity-onset diabetes of the young in Emirati patients by looking at your diabetes history and test results. It may help doctors better classify your diabetes so you can get the most appropriate care.
This study looks for people at high risk of developing type 1 diabetes (based on family history or blood markers) and follows them over time to understand disease development. The goal is to eventually prevent or delay type 1 diabetes in people who don't have it yet.
This study looks for a type of diabetes called MODY that runs in families. It aims to improve diagnosis and treatment for people diagnosed with diabetes at a young age.
This trial is looking for children with newly diagnosed type 1 diabetes to study how to detect the condition earlier. It focuses on kids who have already reached the stage where symptoms appear, to improve understanding of the disease.
Hear when a new Monogenic Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.